Fol. Biol. 2004, 50, 58-62
https://doi.org/10.14712/fb2004050020058
Cytopathological Basis of Heart Failure - Cardiomyocyte Apoptosis, Interstitial Fibrosis and Inflammatory Cell Response
References
1. 2003) Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J. Am. Coll. Cardiol. 41, 753-760.
< , A., Biondi-Zoccai, G. G., Bussani, R., Dobrina, A., Camilot, D., Feroce, F., Rossiello, R., Baldi, F., Silvestri, F., Biasucci, L. M, Baldi, A. (https://doi.org/10.1016/S0735-1097(02)02959-5>
2. 1996) Myocyte death in heart failure. Curr. Opin. Cardiol. 11, 245-251.
< , P., Kajstura, J., Olivetti, G. (https://doi.org/10.1097/00001573-199605000-00004>
3. 1991) Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32, 223-254.
< , M. J. Wyllie, A. H. (https://doi.org/10.1016/B978-0-12-364932-4.50010-1>
4. 2000) Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure. Lab. Invest. 80, 123-133.
< , D., Belikova, Y., Mohammadzadeh, R., Trouve, P., Marotte, F., Russo-Marie, F., Samuel, J. L., Charlemagne, D. (https://doi.org/10.1038/labinvest.3780016>
5. 1995) The regulation of collagen deposition in the hypertrophying heart. Ann. N. Y. Acad. Sci. 752, 236-239.
< , J. E., Rhodes, S., Laurent, G. J., Low, R. B., Stirewalt, W. S. (https://doi.org/10.1111/j.1749-6632.1995.tb17432.x>
6. 2003) Functional structure and composition of the extracellular matrix. J. Pathol. 2003, 423-428.
< , F. T., Stamenkovic, I. (https://doi.org/10.1002/path.1437>
7. 2000) Aldosterone and myocardial fibrosis in heart failure. Herz 25, 299-306.
< , C. G. (https://doi.org/10.1007/s000590050024>
8. 1995) Hormonal regulation of cardiac fibroblast function. Eur. Heart J. 16, (Suppl. C) 45-50.
< , C. G., Maisch, B., Zhou, G., Weber, K. T. (https://doi.org/10.1093/eurheartj/16.suppl_C.45>
9. 1995) Stretch-induced programmed myocyte cell death. J. Clin. Invest. 96, 2247-2259.
< , W., Li, B., Kajstura, J., Li, P., Wolin, M. S., Sonnenblick, E. H., Hintze, T. H., Olivetti, G., Anversa, P. (https://doi.org/10.1172/JCI118280>
10. 1995) Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 147, 325-338.
, J. P., Verluyten, M. J., Smiths, J. F., Daemen, M. J. (
11. 1999) The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc. Res. 44, 232-241.
< , J. P., Blankesteijn, W. M., Daemen, M. J., Smits, J. F. (https://doi.org/10.1016/S0008-6363(99)00212-6>
12. 1999) Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis. Springer Semin. Immunopathol. 21, 415-429.
< , B., Kessler, D., Aumailley, M., Krieg, T. (https://doi.org/10.1007/BF00870303>
13. 1993) New concepts about the mast cell. N. Engl. J. Med. 328, 257-265.
, S. J. (
14. 2003) Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. Am. J. Physiol. Heart. Circ. Physiol. 285, H813-H821.
< , I. C., Sun, Y., Ahokas, R. A., Wodi, L. A., Bhattacharya, S. K., Warrington, K. J., Postlethwaite, A. E., Weber, K. T. (https://doi.org/10.1152/ajpheart.00113.2003>
15. 2003) The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J. Pathol. 200, 516-525.
< , S., Cleutjens, J. P., Faber, B. C., Creemers, E. E., van Suylen, R. J., Lutgens, E., Cleutjens, K. B., Daemen, M. J. (https://doi.org/10.1002/path.1395>
16. 2003) Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 108, 3036-3041.
< , Y., Chandra, M., Miao, W., Shirani, J., Brown, J. H., Dorn, G. W. 2nd, Armstrong, R. C., Kitsis, R. N. (https://doi.org/10.1161/01.CIR.0000101920.72665.58>
17. 2001) Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab. Invest. 81, 1015-1024.
< , K., Hiroe, M., Nishikawa, T., Ishiyama, S., Shimojo, T., Ohta, Y., Sakakura, T., Yoshida, T. (https://doi.org/10.1038/labinvest.3780313>
18. 2004) Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histol. Histopathol. 19, 517-525.
, K., Hiroe, M., Yoshida, T. (
19. 2000) Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix. Cell Mol. Life Sci. 57, 16-24.
< , J., Heino, J. (https://doi.org/10.1007/s000180050496>
20. 1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. USA 95, 8801-8805.
< , J., Leri, A., Finato, N., Di Loreto, C., Beltrami, C. A., Anversa, P. (https://doi.org/10.1073/pnas.95.15.8801>
21. 2002) Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106, 130-135.
< , F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., Imaizumi, T. (https://doi.org/10.1161/01.CIR.0000020689.12472.E0>
22. 2003) Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension 41, 819-823.
< , F., Kai, H., Tokuda, K., Niiyama, H., Tahara, N., Kusaba, K., Takemiya, K., Jalalidin, A., Koga, M., Nagata, T., Shibata, R., Imaizumi, T. (https://doi.org/10.1161/01.HYP.0000056108.73219.0A>
23. Kuwahara, F., Kai, H., Tokuda, K., Takeya, M., Takeshita, A., Egashira, K., Imaizumi, T. (2004) Hypertensive myocardial fibrosis and diastolic dysfunction. Hypertension (Epub ahead of print)
24. 2001) Heart regeneration in adult MRL mice. Proc. Natl. Acad. Sci. USA 98, 9830-9835.
< , J. M., Bedelbaeva, K., Samulewicz, S., Zhang, X. M., Zwas, D., Lankford, E. B., Heber-Katz, E. (https://doi.org/10.1073/pnas.181329398>
25. 1992) The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts. Transplantation 53, 1047-1051.
< , Q. Y., Raza-Ahmad, A., MacAulay, M. A., Lalonde, L. D., Rowden, G., Trethewey, E., Dean, S. (https://doi.org/10.1097/00007890-199205000-00015>
26. 2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 46, 214-224.
< , Y. Y., McTiernan, C. F., Feldman, A. M. (https://doi.org/10.1016/S0008-6363(00)00003-1>
27. 2000) Induction of cardiac fibrosis by transforming growth factor-beta. Mol. Genet. Metab. 71, 418-435.
< , P. J., Petrov, V. V., Fagard, R. H. (https://doi.org/10.1006/mgme.2000.3032>
28. 1960) Heart failure from the point of view of quantitative anatomy. Am. J. Cardiol. 5, 370-382.
< , A. J. (https://doi.org/10.1016/0002-9149(60)90084-9>
29. 2003) Myocyte apoptosis: programming ventricular remodeling. J. Am. Coll. Cardiol. 41, 761-764.
< , K., Kitsis, R. N. (https://doi.org/10.1016/S0735-1097(02)02958-3>
30. 1996) Apoptosis in myocytes in endstage heart failure. N. Engl. J. Med. 335, 1182-1189.
< , J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., Khaw, B. A. (https://doi.org/10.1056/NEJM199610173351603>
31. 1995) Gender differences and aging: effects on the human heart. J. Am. Coll. Cardiol. 26, 1068-1079.
< , G., Giordano, G., Corradi, D., Melissari, M., Lagrasta, C., Gambert, S. R., Anversa, P. (https://doi.org/10.1016/0735-1097(95)00282-8>
32. 1997) Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131-1141.
< , G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., Reed, J. C., Anversa, P. (https://doi.org/10.1056/NEJM199704173361603>
33. 1995) Are mast cells involved in hypertensive heart disease? J. Hypertens. 13, 1201-1208.
< , A., Mindan, F. J., Galindo, M. F., Cenarruzabeitia, E., Hernandez, M., Diez, J. (https://doi.org/10.1097/00004872-199510000-00015>
34. 1999) Morphometrical and stereological analysis of myocardial mast cells in myocarditis and dilated cardiomyopathy. Folia Biol. (Praha) 45, 63-66.
, D., Zorc, M., Zorc-Pleskovic, R., Vraspir-Porenta, O. (
35. 2000) Apoptosis and proliferation of cardiomyocytes in heart failure of different etiologies. Cardiovasc. Pathol. 9, 149-152.
< , D., Zorc-Pleskovic, R., Zorc, M. (https://doi.org/10.1016/S1054-8807(00)00032-6>
36. 1986) The heart as a suction pump. Sci. Am. 254, 84-91.
< , T. F., Factor, S. M., Sonnenblick, E. H. (https://doi.org/10.1038/scientificamerican0686-84>
37. 1998) Images in cardiovascular medicine. Connective tissue skeleton of the human heart: a demonstration by cell-maceration scanning electron microscope method. Circulation 97, 934-935.
< , M. A., Abreu, M. A., Santoro, L. B. (https://doi.org/10.1161/01.CIR.97.9.934>
38. 1995) Progression of heart failure: a role for interstitial fibrosis. Mol. Cell Biochem. 147, 29-34.
< , H. N., Sharov, V. G., Lesch, M., Goldstein, S. (https://doi.org/10.1007/BF00944780>
39. 1998) Programmed cell death in the progression of heart failure. Ann. Med. 30 (Suppl. 1) 33-38.
, H. N., Sharov, V. G., Goldstein, S. (
40. 1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur. J. Clin. Invest. 29, 380-386.
< , A., Pulkki, K., Kallajoki, M., Heikkila, P., Laine, P., Mattila, S., Nieminen, M. S., Parvinen, M., Voipio-Pulkki, L. M. (https://doi.org/10.1046/j.1365-2362.1999.00481.x>
41. 2003) A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J. Hypertens. 21, 1935-1944.
< , N., Rysa, J., Kovanen, P. T., Ruskoaho, H., Kokkonen, J. O., Lindstedt, K. A. (https://doi.org/10.1097/00004872-200310000-00022>
42. 2000) Infarct scar: a dynamic tissue. Cardiovasc. Res. 46, 250-256.
< , Y., Weber, K. T. (https://doi.org/10.1016/S0008-6363(00)00032-8>
43. 1999) Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79, 215-262.
< , B. (https://doi.org/10.1152/physrev.1999.79.1.215>
44. 1998) Caspases: enemies within. Science 281, 1312-1316.
< , N. A., Lazebnik, Y. (https://doi.org/10.1126/science.281.5381.1312>
45. 2004) From inflammation to fibrosis: a stiff stretch of highway. Hypertension 43, 000-000 [Epub ahead of print]
< , K. T. (https://doi.org/10.1161/01.HYP.0000118586.38323.5b>
46. 1993) Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res. 27, 341-348.
< , K. T., Brilla, C. G., Janicki, J. S. (https://doi.org/10.1093/cvr/27.3.341>
47. 1988) Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ. Res. 62, 757-765.
< , K. T., Janicki, J. S., Shroff, S. G., Pick, R., Chen, R. M., Bashey, R. I. (https://doi.org/10.1161/01.RES.62.4.757>
48. 2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111, 1497-1504.
< , D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., Kitsis, R. N. (https://doi.org/10.1172/JCI17664>
49. 2001) Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 103, 155-160.
< , A. J., Tsotetsi, O. J., Sprott, S., Lancaster, E. J., Mela, T., Chung, E. S., Meyer, T. E., Norton, G. R. (https://doi.org/10.1161/01.CIR.103.1.155>
50. 2003) Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. Cardiovasc. Pathol. 12, 36-39.
< , M., Vraspir-Porenta, O., Zorc-Pleskovic, R., Radovanovic, N., Petrovic, D. (https://doi.org/10.1016/S1054-8807(02)00134-5>